Trial Profile
Cholesterol 7alpha-hydroxylase polymorphism as a predictor cholesterolemia responsiveness
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 24 Jun 2014
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacogenomic; Therapeutic Use
- 24 Jun 2014 New trial record